Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | ROIV | ASND | ||
| Company | Intra-Cellular Ther | Roivant Sciences Ltd | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 21.85 | 210.32 | ||
| High | 131.98 | 22.31 | 210.44 | ||
| Low | 131.63 | 21.80 | 204.52 | ||
| Latest | 131.87 | 22.17 | 208.78 | ||
| Change | -0.05 | +0.27 | -4.46 | ||
| % Change | -0.04% | +1.23% | -2.09% | ||
| Volume | 16,062,900 | 1,784,422 | 277,667 | ||
| 20-Day Average Volume | 2,474,570 | 6,838,204 | 683,176 | ||
| Previous Close | 131.92 | 21.90 | 213.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 20.82 | 208.57 | ||
| 20-Day Raw Stochastic | 86.25% | 80.19% | 41.16% | ||
| 20-Day Relative Strength | 82.75 | 66.76 | 50.96 | ||
| Weighted Alpha | +83.21 | +122.18 | +50.74 | ||
| Today's Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 96% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +7.91% since 12/09/25 | +5.67% since 12/09/25 | ||
| Low | 131.63 on 04/01/25 | 20.14 on 12/10/25 | 192.28 on 12/10/25 | ||
| High | 131.98 on 04/01/25 | 22.56 on 12/15/25 | 229.94 on 12/12/25 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | +8.65% since 11/14/25 | +1.65% since 11/14/25 | ||
| Low | 131.18 on 03/05/25 | 19.96 on 12/02/25 | 192.28 on 12/10/25 | ||
| High | 131.98 on 04/01/25 | 22.56 on 12/15/25 | 229.94 on 12/12/25 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +55.47% since 09/16/25 | +5.35% since 09/16/25 | ||
| Low | 80.82 on 01/07/25 | 14.50 on 09/24/25 | 186.05 on 10/20/25 | ||
| High | 131.98 on 04/01/25 | 22.56 on 12/15/25 | 229.94 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +98.96% since 06/16/25 | +16.92% since 06/16/25 | ||
| Low | 70.90 on 10/07/24 | 10.70 on 07/08/25 | 160.86 on 07/29/25 | ||
| High | 131.98 on 04/01/25 | 22.56 on 12/15/25 | 229.94 on 12/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 15,231,275 | 13,206,379 | ||
| Shares Outstanding, K | 106,522 | 695,492 | 61,932 | ||
| Annual Sales | 680,850,000 | 29,050,000 | 393,500,000 | ||
| Annual Net Income | -74,680,000 | -171,980,000 | -409,120,000 | ||
| Last Quarter Sales | 199,220,000 | 1,570,000 | 249,720,000 | ||
| Last Quarter Net Income | -16,890,000 | -113,520,000 | -71,290,000 | ||
| 60-Month Beta | 0.46 | 1.22 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | -0.28 on 11/10/25 | -1.17 on 11/12/25 | ||
| Latest Earnings Date | 05/06/25 | 02/09/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||